Get 20% lifetime commission for referring investors to digrin.com
here.
Larimar Therapeutics, Inc. ( LRMR) - Key Metrics
LRMR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.32 | -$0.42 | -$0.43 |
| 2026Q1 | $0 | -$0.35 | -$0.52 | -$0.52 |
| 2025Q4 | $0 | -$0.73 | -$0.45 | -$0.45 |
| 2025Q3 | $0 | -$0.61 | -$0.37 | -$0.37 |
| 2025Q2 | $0 | -$0.41 | -$0.30 | -$0.30 |
LRMR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.54 |
| 2026Q1 | 0% | -3.21 |
| 2025Q4 | 0% | -1.30 |
| 2025Q3 | 0% | -1.32 |
| 2025Q2 | 0% | -1.76 |
LRMR
Price: $4.32
52 week price:
Earnings Per Share: -2.01 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 194
Market Capitalization: 452.9 million